UOC
PIIIW icon

UBS O'Connor’s P3 Health Partners Inc Warrant PIIIW Stock Holding History

UBS O'Connor’s Portfolio PIIIW Stock Details PIIIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-166,660
Closed -$151K – 992
2021
Q3 		$151K Hold
166,660
– – ﹤0.01% 764
2021
Q2 		$232K Buy
+166,660
New +$170K ﹤0.01% 700

Other funds holding PIIIW

LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
AC
Athos Capital Hong Kong $282M AUM 11.4% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
KC
Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return
CF
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return

UBS O'Connor's PIIIW Position: Q4 2021 in Review

UBS O'Connor sold out of P3 Health Partners Inc Warrant (PIIIW) in Q4 2021, closing a stake of 166,660 shares — an estimated $151K sold.

UBS O'Connor first reported a position in PIIIW in Q2 2021 and held it in 2 quarters. The position peaked at $232K in Q2 2021. 40 funds tracked by Wall St. Rank hold PIIIW as of Q4 2021.

  • UBS O'Connor reported no remaining P3 Health Partners Inc Warrant position as of Q4 2021 after selling out during the quarter.
  • UBS O'Connor sold 166,660 P3 Health Partners Inc Warrant shares in Q4 2021, an estimated $151K.
  • UBS O'Connor first reported a position in P3 Health Partners Inc Warrant in Q2 2021 and held it in 2 quarters.
  • UBS O'Connor's P3 Health Partners Inc Warrant position peaked at $232K in Q2 2021.
  • 40 funds tracked by Wall St. Rank held P3 Health Partners Inc Warrant as of Q4 2021.

Based on UBS O'Connor's 13F filing for Q4 2021, filed 14 Feb 2022.